High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered

This publication has 52 references indexed in Scilit:

• Deleterious Effects of Anabolic Steroids on Serum Lipoproteins, Blood Pressure, and Liver Function in Amateur Body Builders
  International Journal of Sports Medicine, 1988
• Increase in Hepatic Lipase Activity after Testosterone Substitution in Men with Hypogonadism of Pituitary Origin
  Acta Medica Scandinavica, 1987
• Biologic Effects of Transdermal Estradiol
  New England Journal of Medicine, 1986
• Response of serum testosterone and its precursor steroids, SHBG and CBG to anabolic steroid and testosterone self-administration in man
  The Journal of Steroid Biochemistry and Molecular Biology, 1985
• Serum high density lipoprotein subclasses, testosterone and sex-hormone-binding globulin in Trinidadian men of African and Indian descent
  Atherosclerosis, 1985
• Reduced High-Density Lipoprotein-Cholesterol in Power Athletes: Use of Male Sex Hormone Derivates, an Atherogenic Factor
  International Journal of Sports Medicine, 1984
• High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use
  JAMA, 1984
• Plasma testosterone, high density lipoprotein cholesterol and other lipoprotein fractions
  The American Journal of Cardiology, 1981
• Hyperplasia and prolapse of hepatocytes into hepatic veins during longterm methyltestosteronetherapy: possible relationships of these changes to the development of peliosis hepatis and liver tumours
  Histopathology, 1977
• Effect of estrogen on post-heparin lipolytic activity. Selective decline in hepatic triglyceride lipase.
  Journal of Clinical Investigation, 1977